Opioid Induced Constipation Drugs Market

Opioid Induced Constipation Drugs Market contains market size and forecasts of Opioid Induced Constipation Drugs in global, including the following market information:

• Global Opioid Induced Constipation Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Opioid Induced Constipation Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
• Global top five Opioid Induced Constipation Drugs companies in 2021 (%)

The global Opioid Induced Constipation Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Lubiprostone Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Opioid Induced Constipation Drugs include Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co., Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma and S.L.A. Pharma AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Opioid Induced Constipation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Opioid Induced Constipation Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Opioid Induced Constipation Drugs Market Segment Percentages, by Type, 2021 (%)

• Lubiprostone
• Methyl Naltrexone Bromide
• Naldemedine
• Alvimopan
• Others

Global Opioid Induced Constipation Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Opioid Induced Constipation Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Opioid Induced Constipation Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Opioid Induced Constipation Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Opioid Induced Constipation Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Opioid Induced Constipation Drugs revenues share in global market, 2021 (%)
• Key companies Opioid Induced Constipation Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
• Key companies Opioid Induced Constipation Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Ironwood Pharmaceuticals Inc
• Daiichi Sankyo Co Ltd
• Pfizer
• Progenics Pharmaceuticals Inc
• Shionogi & Co., Ltd
• Allergan Plc
• Nektar Therapeutics
• Purdue Pharma
• S.L.A. Pharma AG
• Mundipharma International Limited
• Ono Pharmaceutical Co., Ltd
• Takeda Pharmaceutical Company Limited
• Theravance Biopharma Inc
• Bausch Health
• Cosmo Pharmaceuticals SA
• Daewoong Pharmaceutical
• C.B. Fleet Company
• Sucampo Pharmaceuticals